Research and Analytics
Providence physicians and scientists are working side-by-side, across borders to create solutions to ensure that patients benefit from the latest advancements in COVID-19 prevention, diagnosis, and treatment. Learn about our initiatives to share data and discoveries, and apply this knowledge so that we all remain poised and ready to act.
Alliance for Research on COVID-19 (ARC)
To ensure that no health system has to weather a storm like the COVID-19 crisis alone, Providence created a non-profit data alliance that includes health systems and others dedicated to COVID-19 research. Under this alliance, de-identified patient data is only used for COVID-19 related research. There is no fee to join and data will not be sold.
- Predictive Monitoring, Analytics, and Modeling
- Operational Reporting
- Clinical Decision Support
- Epidemiology Insights
- Caregiver Insights
Providence’s work across institutions can help save lives and establish the foundation for eventual recovery within our communities.
Researchers from the Chiles Research Institute at Providence’s Robert Franz Cancer Center are currently working on a COVID-19 vaccine based on the virus structure and the body’s immune response.
In the news
- Providence develops potential COVID-19 vaccine; wants feds to start human clinical trials
- 21 companies are working on coronavirus treatments or vaccines
- Providence coronavirus vaccine proposal centers on cancer-fighting technique
Learn more about Providence’s institute model for specialty care.
In addition to our ongoing work with more than 2,300 clinical trials, Providence is partnering with Gilead Sciences Inc. on COVID-19 clinical trials and testing of prescribed medications.
In the news
- COVID – 19 Experimental Drug Cleared for Clinical Trials in Humboldt County
- St. Joseph Hospital patient enters clinical trial for possible COVID-19 drug
- More Encouraging Signs for Remdesivir as COVID-19 Treatment
The Coronavirus Epidemic Registry and Emergency Data Platform enables health systems to track COVID-19 patient census and resources they are utilizing in each facility, such as ICU beds, ventilators, and PPE. The tool also helps us understand community penetration of the virus by zip code with data that informs challenging resource decisions. It can tell us when to initiate universal masking and how to shift supplies between regions to accommodate an anticipated patient surge.